The Investigator-Sponsored Studies (ISS) Program supports independent researchers conducting clinical and observational studies to address evidence gaps in Novo Nordisk therapeutic areas and improve patient outcomes.
Investigator Initiated Studies (IIS) supports external, non-commercial sponsors conducting independent clinical, observational, real-world evidence, and health outcomes research to explore scientific questions.
Investigator Sponsored Research Program supports independent investigators studying Medtronic products, services, and therapies to build clinical evidence and improve patient care.
Investigator-initiated trials (IITs) support independent investigators and academic sponsors conducting clinical and non-clinical research to advance knowledge about Lundbeck compounds and improve patients’ lives.
Ionis Pharmaceuticals' Investigator‑Initiated Research Program funds independent studies advancing science in cardiovascular, hereditary angioedema, and neurological diseases.